Clinical Trial

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - EU

Study acronym: REMIND-EU
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety and feasibility of the Symani System and microsurgical techniques in the deep Cervical Lymph Node (dCLN) region in patients with confirmed Alzheimer's disease.
Trial Details
NCT Number NCT07708675
Lead Sponsor MMI (Medical Microinstruments, Inc.)
Conditions Alzheimer's
Enrollment 50 participants
Start Date 2026-10-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-16